期刊文献+

西地那非与前列腺素E_1治疗猪肺动脉高压 被引量:5

Sildenafil and prostaglandin E_1 treated pulmonary hypertension on piglet model
下载PDF
导出
摘要 目的比较西地那非和前列腺素E1对幼猪肺动脉高压模型的影响。方法体质量约5kg实验用健康幼猪24只,用经气管内吸入胎粪法诱发幼猪产生肺动脉高压,2h后建立急性缺氧性肺动脉高压模型。随机将幼猪分成4组:对照组,不给予任何药物治疗;西地那非组,静脉注射枸橼酸西地那非(2mg/kg)、前列腺素E1组,持续静脉滴注前列腺素E120ng/(kg·min)至实验结束;合用组同时给予西地那非组和前列腺素E1。结果吸入胎粪2h后,记录动物的肺动脉压、肺血管阻力(pulmonary vascular resistance,PVR)和体循环血管阻力(systemic vascular resistance,SVR)。发现肺动脉压、PVR和PVR/SVR均随时间明显增加。施加药物干预以后,西地那非组与合用组的上述指标均明显迅速下降,并且心输出量和心脏指数明显提高;前列腺素E1组肺动脉压、PVR以及PVR/SVR下降程度不如西地那非组明显,心输出量、心脏指数无改善;对照组的肺动脉压、PVR以及PVR/SVR无下降。结论西地那非降低肺动脉压和肺血管阻力,改善心功能,同时对体循环血流动力学无不良影响;在本实验用量,西地那非扩张肺血管和降低肺血管阻力的作用比前列腺素E1强;两者联合应用没有发生协同降低肺动脉压作用。 Objectives To investigate the effects of intravenous sildenafil on pulmonary and systemic hemodynamics in a piglet model of acute pulmonary hypertension secondary to meconium aspiration, to compare these effects of prostaglandin E1 and the combination of sildenafil and prostaglandin E1. Methods Pulmonary hypertension was induced in 24 piglets by endotracheal instillation of human meconium. Animals were assigned to four groups randomly after meconium aspiration over 2 hours. Each group had six piglets. Group A received no any additional intervention, group B received an infusion of intravenous sildenail 2 mg/kg for 2 hours, group C received continually intravenous infusion prostaglandin E1 20 ng/kg per min for 2 hours, group D received both of what were done in A and B groups. Results All piglets' pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR) and the rate of pulmonary-to-systemic vascular resistance (PVR/ SVR) increased remarkably after meconium aspiration over 2 hours. There was no further change of the PAP, PVR and PVR/SVR of group A after medicine intervention. Those of group B and D decreased remarkably. The cardiac output (CO) and cardiac index (CI) of group B and D increased at the same time. Similar changes were seen in both group B and D. PAP, PVR, PVR/SVR of group C also decreased, but less than those of group B and D. CO and CI in group C were not improved. Conclusions Sildenafil decreases PAP and PVR, improves heart function, unchanges systemic hemodynamics. Its potency is stronger than that of prostaglandin E1 at this experiment dosage. Effects can be augdmented under combination of two drugs.
机构地区 广东省人民医院
出处 《岭南心血管病杂志》 2007年第3期217-220,共4页 South China Journal of Cardiovascular Diseases
关键词 西地那非 前列腺素E1 肺动脉高压 小猪 Sildenafil Prostaglandin E1 Pulmonary hypertension Piglet
  • 相关文献

参考文献8

  • 1LYONS JM,DUFFY JY,WAGNER CJ,et al.Sildenafil citrate alleviates pulmonary hypertension after hypoxia and reoxygenation with cardiopulmonary bypass[J].J Am Coll surg,2004,199(4):607-614.
  • 2SHEKERDEMIAN LS.RAVN HB,PENNY DJ.Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension[J].Am J Respir Crit Care Med,2002,165(8):1098-1102.
  • 3WILKENS H,GUTH A,KONIG J,et al.Effect of inhalted iloprost plus oral sildenafil in patients with primary pulmonary hypertension[J].Circulation,2001,104(11):1218-1222.
  • 4DAVEY AM,BECKER JD,DAVIS JM.Meconium aspiration syndrome:physiological and inflammatory changes in a newborn pitlet model[J].Pediatr Pulmonol,1993,16(2):101-108.
  • 5ICHINOSE F,ERANA-GARCIA J,HROMI J,et al.Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension[J].Crit Care Med,2001,29(5):1000-1005.
  • 6曾嵘,庄建,岑坚正,陈欣欣,熊卫萍,朱卫中.枸橼酸西地那非治疗心脏手术后肺动脉高压的临床研究[J].中华心血管病杂志,2005,33(10):916-919. 被引量:28
  • 7WATANABE H,OHASHI K,TAKEUCHI K,et al.Sildenafil for primary and secondary pulmonary hypertension[J].Clin Pharmacol ther,2002,71(5):3 98-402.
  • 8MICHELAKIS E,TYMCHAK W,LIEN D,et al.Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension:comparison with inhalted nitric oxide[J].Circulation,2002,105(20):2398-2403

二级参考文献7

  • 1Berner M, Beghetti M, Spahr-Schopfer I,et al. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.Am J Cardiol, 1996,77:532-535.
  • 2Assreuy J, Cunha FQ, Liew FY, et al. Feedback inhibition of nitric oxide synthase activity by nitric oxide.Br J Pharmacol, 1993,108:833-837.
  • 3Wallis RM, Corbin JD, Francis SH,et al. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.Am J Cardiol,1999,83(suppl 5A):3C-12C.
  • 4Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med, 2002, 165:1098-1102.
  • 5Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med, 2002,136:515-522.
  • 6Watanabe H, Ohashi K, Takeuchi K, et al. Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther,2002,71:398-402.
  • 7李禄全,余加林,周玲.婴儿猝死综合征病因研究近况[J].医学综述,2001,7(10):613-615. 被引量:6

共引文献27

同被引文献78

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部